supplier

ROVI Biotech Ltd

CR01QQ combined from 3 published records

as a supplier

22 recorded awards from 6 buyers , between 8 Jan 2018 and 13 Jan 2026.

awards won

exclusive

0 sole-winner awards

median award

£240.8m

largest

£428.2m

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

buyer	awards
NHS England	11
Procurement and Logistics Service	4
NHS England	3
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")	2
Atamis Ltd	1
The NHS Commissioning Board (operating under the name of NHS England)	1

contracts won

contract	buyer	value	awarded
NHS National Generic Pharmaceuticals - Wave 15c shared	NHS England	£403,702,000	13 Jan 2026
NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products shared	NHS England	£321,349,256	28 Nov 2025
NHS Framework Agreement for Branded Medicines - Proprietary Category Tender shared	NHS England	£1,241,520,444	24 Mar 2025
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1) shared	NHS England	£1	4 Mar 2024
CM/PHR/22/5687 - NHS National Proprietary Low Molecular Weight Heparins shared	NHS England	£186,609,000	13 Jul 2023
NHS National Generic Pharmaceuticals Wave 14b shared	ATAMIS LTD	£428,226,984	6 Jul 2023
NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals shared	NHS England	£304,504,000	23 Apr 2023
NHS Framework Agreement for Branded medicines - London - Tranche B - Contracts Finder Opportunity shared	NHS England	£251,930,337	4 Jul 2019
NHS England - Midlands and East Branded Medicines - Tranche B shared	NHS England	£295,035,882	17 Jan 2019
NHS England Framework Agreement: South of England (Tranche B) shared	NHS England	£501,400,000	13 Sept 2018
NHS Framework Agreement - North of England - Tranche B shared	NHS England	£521,100,000	13 Feb 2018
NHS Framework Agreement - North of England - Tranche B shared	NHS England	£521,100,000	8 Jan 2018
NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products shared	NHS England	·	18 Dec 2025
NP30925 Psychiatry and Neurology Medicines shared	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	·	18 Aug 2025
NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025 shared	NHS England	·	22 Apr 2025
Medicinal Products Distribution and Associated Services [5009879] shared	Procurement and Logistics Service	·	21 Jun 2024
NP35923 Cardiovascular & Respiratory Medicines shared	The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")	·	25 Jul 2023
NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals shared	NHS England	·	6 Apr 2023
Medicinal Products and Pharma Funded Homecare Services shared	Procurement and Logistics Service	·	23 Jul 2021
Medicinal Products and Pharma Funded Homecare Services shared	Procurement and Logistics Service	·	23 Jul 2021
Medicinal Products and Pharma Funded Homecare Services shared	Procurement and Logistics Service	·	23 Jul 2021
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies. shared	The NHS Commissioning Board (operating under the name of NHS England)	·	23 Feb 2021

every contract won by ROVI Biotech Ltd →

as published

This page combines 3 separate records from the source data. Every one is listed below exactly as the publisher filed it, so you can check the grouping yourself.

name as published	identifier	postcode	records
ROVI Biotech Ltd	·	CR0 1QQ	16
ROVI BIOTECH LIMITED	GB-COH 09339446	·	3
ROVI Biotech Ltd	GB-PPON PBDB-7444-GRNW	CR0 1QQ	3

why these were combined

Matching uses organisation identifiers where publishers provide them, falling back to name and address. Records are never combined on address alone, because one shared-service postcode carries 244 different organisations. how this works